Alice Lorusso Publishes Study on Optimized Pathogen Reduction for Double-Dose Platelets
Alice Lorusso, Senior Medical Scientist at Irish Blood Transfusion Service, posted on LinkedIn:
”Thrilled to share that my paper “Optimized pathogen reduction of double-dose platelets pooled from seven buffy coats using the TACSI system” has been published in Vox Sanguinis.
This study explores how double-dose platelet components can be safely pathogen-reduced while maintaining excellent in-vitro quality and compliance with EDQM specifications.
Grateful to my co-authors and colleagues for the teamwork and dedication that made this possible ”
Read the full article here.
Title: Optimized pathogen reduction of double-dose platelets pooled from seven buffy coats using the TACSI® system
Authors: Alice Lorusso, Liam Morgan, Aileen Farrelly, Mark Lambert, Barry Doyle, Paul Hendrick, Einas Elsheikh, Andrew Godfrey, Tor Hervig, Allison Waters
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 11:16Christina Pohlman: Could aPL Levels Help Predict Stroke Recurrence?
-
Sep 30, 2026, 10:55Rana Al Hrout: Diagnostic Approach to Hypochromic Microcytic Anemia
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling